FDA PMA FDA Class 3 Approved 🇺🇸 United States

Cancer-Related Germline Gene Mutation Detection System

PMA: P140020 · Supplement: S007 · Decision Jun 17, 2016
Classifications
1
FEI Numbers
1
Registration Numbers
1

Basic Information

Device Name
Cancer-Related Germline Gene Mutation Detection System
Trade Name
BRACANALYSIS CDx
PMA Number
P140020
Supplement Number
S007
Device Class
FDA Class 3
Product Code
PJG
Generic Name
Cancer-related germline gene mutation detection system
Medical Specialty
Unknown
Advisory Committee
Pathology
Decision
Approved
Decision Code
APPR
Decision Date
June 17, 2016
Date Received
June 7, 2016
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval to remove the DNA extraction system from serialization, and to remove non-critical instruments from the specified device components.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PJG Cancer-Related Germline Gene Mutation Detection System